Click it and Unblock the Notifications
Latest Updates
-
Antacid Overuse in Cold Months Is Disrupting Gut Health: Expert Weighs In -
Kannan Pattambi, Veteran Malayalam Actor and Film Production Controller, Passes Away At 62 -
The Hidden Link Between Poor Posture and Chronic Fatigue: Expert Weighs In -
The Sunday Cheat Meal Myth: Expert Explains How Weekend Indulgence Affects Heart Health More Than You Think -
From 135 kg to 89 kg: How Nitin Gadkari’s Post-COVID-19 Wake-Up Call Redefined His Health -
Gold Rate in India Today, Jan 5: 24K, 22K, 18K Prices Surge as US-Venezuela Crisis Sparks Buying; Silver Rallies Too -
National Keto Day Guide: How Beginners Can Start Keto Without Feeling Overwhelmed -
BTS Confirms Full-Group Comeback After Nearly Four Years: New Album and World Tour Announced -
Actress Sudha Chandran Becomes Emotional at Mata Ki Chowki; Video Sparks Online Reactions -
National Bird Day 2026: Why These Feathered Creatures Are Vital And How Small Actions Protect Wildlife
Government Bans High-Dose Nimesulide In India, Doctors Asked To Switch To Safer Options
If you've ever taken a painkiller for a headache, fever, or body pain, chances are you've heard of Nimesulide. From early 2026, the Indian government has banned all oral medicines containing Nimesulide in doses above 100 mg. This ban applies immediately to tablets, capsules, and syrups in immediate-release form. Essentially, those stronger versions are no longer allowed to be manufactured, sold, or distributed in India.
What's Banned And What's Still Allowed
Here's the breakdown:
- Banned: All oral Nimesulide formulations with more than 100 mg per dose in immediate-release form.
- Still allowed: Oral doses up to 100 mg, extended-release formulations, and topical versions like gels or creams remain available.
So, this isn't a total ban on the medicine, only the higher-strength oral forms that have been linked to safety concerns.
Why The Ban Happened
The government didn't make this decision lightly. Here's why high-dose Nimesulide is being restricted:
Health risks: Higher doses have been associated with liver damage, kidney problems, and other side effects.
Expert advice: Top medical advisory bodies in India reviewed safety data and recommended limiting the use of high-dose Nimesulide.
Safer alternatives exist: There are other painkillers and anti-inflammatory medicines that are considered safer for regular use.
In short, regulators decided the risks of high-dose Nimesulide outweighed the benefits, especially when safer options are available.
What This Means For Patients And Doctors
If you or someone you know has been prescribed Nimesulide above 100 mg:
Doctors will adjust prescriptions: Practitioners should now recommend lower doses or alternative medications.
Consult before switching: Patients should not stop or change their medicine on their own; always speak to a doctor first.
Pharmacies will comply: Existing stock of banned formulations must be removed from shelves.
This ensures that people continue to get effective pain relief without unnecessary risks.
The Significance Of The Ban
NSAIDs like Nimesulide are among the most commonly used medicines in India. Tightening rules around a widely used drug highlights the government's focus on patient safety and responsible prescribing. It also reminds everyone that stronger isn't always better when it comes to medication.
High-dose Nimesulide is officially off the market. The move is aimed at protecting people from avoidable harm, while still allowing access to safer alternatives. If you've been using or prescribing this medicine, now is the time to review treatment options with a healthcare professional. Patient safety comes first, and this step is a clear example of proactive regulation in action.
Continue with Google